daidzin has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Liu, X; Qu, L; Xu, H; Xu, K | 1 |
| Backlund, M; Ingelman-Sundberg, M | 1 |
2 other study(ies) available for daidzin and Cancer of Liver
| Article | Year |
|---|---|
Daidzin inhibits hepatocellular carcinoma survival by interfering with the glycolytic/gluconeogenic pathway through downregulation of TPI1.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Gene Expression Regulation, Neoplastic; Isoflavones; Liver Neoplasms; Mice; Mice, Nude | 2022 |
Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases.
Topics: Amino Acid Substitution; Animals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Genistein; Isoflavones; Ligands; Liver Neoplasms; Mutagenesis, Site-Directed; Omeprazole; Rats; Receptor Protein-Tyrosine Kinases; Receptors, Aryl Hydrocarbon; Recombinant Fusion Proteins; Recombinant Proteins; Signal Transduction; Spodoptera; src-Family Kinases | 2005 |